Annis Gardner Whiting Capital Advisors, LLC Moderna, Inc. Transaction History
Annis Gardner Whiting Capital Advisors, LLC
- $357 Billion
- Q4 2024
A detailed history of Annis Gardner Whiting Capital Advisors, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Annis Gardner Whiting Capital Advisors, LLC holds 5,441 shares of MRNA stock, worth $183,688. This represents 0.06% of its overall portfolio holdings.
Number of Shares
5,441
Previous 4,716
15.37%
Holding current value
$183,688
Previous $315 Million
28.22%
% of portfolio
0.06%
Previous 0.09%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
925Shares Held
256MCall Options Held
19MPut Options Held
24.3M-
Vanguard Group Inc Valley Forge, PA40.3MShares$1.36 Billion0.03% of portfolio
-
Baillie Gifford & CO38.9MShares$1.31 Billion1.28% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$863 Million0.07% of portfolio
-
State Street Corp Boston, MA17.6MShares$593 Million0.03% of portfolio
-
Theleme Partners LLP London, X07.31MShares$247 Million20.37% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $13.2B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...